Bain Capital Life Sciences Fund, L.P.
CIK 1687968 · last filed 2023-05-30
Bain Capital Life Sciences Fund, L.P. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing, for DVAX, was dated Oct 24, 2023. Across all open-market trades the lifetime net is +$2.6M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $22.4M across reported positions. The firm reports its address in Boston, MA. 19 SEC filings were submitted jointly with BCIP Life Sciences Associates, LP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ANNX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BOSTON, MA 02116
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANNX | 10%+ Owner | 5,701,926 | $3.94 | $22.44M | $2.56M | 1 | 2023-05-30 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-10-24 | DVAX | Notice (144) | −376,887 | -$5.20M | EDGAR |
| 2023-10-10 | DVAX | Notice (144) | −453,572 | -$6.68M | EDGAR |
| 2023-08-08 | DVAX | Notice (144) | −1,360,717 | -$20.07M | EDGAR |
| 2023-06-14 | DVAX | Notice (144) | −453,572 | -$5.70M | EDGAR |
| 2023-05-30 | ANNX | Buy (P) | +1,200,000 | $2.56M | EDGAR |
| 2023-05-18 | DVAX | Notice (144) | −907,145 | -$10.10M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.